MassDevice.com +3 | The top 3 medtech stories for August 24, 2015

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.   3. ‘Go-shop’ lapses without new rival for St. Jude’s $3B Thoratec buy A 30-day “go-shop” period in St. Jude Medical’s pending, $3.4 billion acquisition of Thoratec lapsed without a 2nd suitor emerging, sending the companies’ stock prices down slightly. The merger, medtech’s latest multi-billion union, calls for St. Jude to pay $63.50 in cash for each share of Pleasanton, Calif.-based Thoratec, funded using term loans and senior unsecured debt. Read more 2. TriVascular Technologies raises $10m, launches study of EVAR in women Trivascular Technologies said it raised a $10 million funding round and launched a clinical study of endovascular aortic repair in women using its Ovation stent graft. Santa Rosa, Calif.-based TriVascular said in a regulatory filing that it raised $10 million from 5 unnamed investors in a debt-and-warrants offering. The company, which won pre-market approval from the FDA this month for its Ovation iX device, raised $78 million in April 2014 with an initial public offering. Read more 1. Vital Therapies trial fails to meet endpoints Vital Therapies said that the Phase...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 3 Source Type: news